CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Novartis [NYSE: NVS]

Carlos Pasquali, Associate Director of Strategic Consulting

Igniting Pharma Innovation Via Cross-Cultural Technology

Carlos Pasquali

Carlos Pasquali

Carlos Pasquali drives pharmaceutical transformation at Novartis as Associate Director, Strategic Consulting. Combining 18+ years of strategy/operational excellence experience with a global mindset from international living/ working, he navigates complex change effectively. He excels at stakeholder engagement and implementing new processes and capabilities, focusing keenly on innovation, especially AI.


A Global Perspective Driving Transformation


Curiosity and cross-cultural fluency are defining traits of Carlos Pasquali's journey. Growing up in Mexico, followed by living and working in the U.S. and Italy, instilled in him an innate ability to connect with diverse teams and navigate complex international environments. This ‘citizen of the world’ perspective proves to be a powerful professional asset, moving beyond personal philosophy. It equips him to grasp nuances, foster connections and design strategies that resonate across different business units and geographies—from North America and Europe to Asia, making him exceptionally effective in global roles at Novartis and previously at EY.


Orchestrating Complex Change in Pharma


Drawing on over 18 years in strategy and operational excellence consulting, Pasquali possesses a rare ability to dissect challenges and architect solutions within the intricate pharmaceutical world. At Novartis, his impact is evident in navigating significant transformations: he has addressed the complex implications of the U.S. Inflation Reduction Act (IRA) on clinical trials, uncovered hundreds of millions in rogue spending and implemented effective controls during major business unit mergers. His expertise shines in identifying pivotal opportunities and skillfully managing the complex web of stakeholders, processes and potential resistance inherent in large-scale change. He excels at building relationships, fostering collaboration and driving critical projects from initial concept to successful implementation.


With a global mindset and a strategist's toolkit, Carlos Pasquali architects transformations that bridge cultures, streamline operations and harness the power of AI to redefine possibilities within the pharmaceutical landscape


Engineering Efficiency, From Code to Capabilities


Pasquali’s strategic mindset is firmly grounded in a practical mastery of systems and efficiency. This was powerfully demonstrated during his tenure as Head of Systems Development at a startup, where he transformed a cumbersome, monolithic codebase spread across 70 AWS instances into a lean, modular system operating on just 15. This feat enabled daily software deploys and positioned the system for national scalability. Such hands-on experience refactoring code and optimizing infrastructure directly informs his broader approach to process improvement and capabilitiesbuilding today. Whether rolling out global systems for smoother healthcare professional interactions at Novartis, constructing sophisticated forecasting and pricing models at EY or even single-handedly creating a high-impact QR code system for municipal services in Zapopan, he consistently identifies pathways to streamline operations and elevate performance. With a global mindset and a strategist's toolkit, Pasquali architects transformations that bridge cultures, simplify operations and harness the power of AI to redefine possibilities within the pharmaceutical landscape.


Championing the Future: AI Integration at Novartis


Recognizing AI as a revolutionary force, particularly within pharmaceuticals, Pasquali actively champions its potential as an enthusiastic ‘AI evangelist.’ He effectively combines his technical understanding and strategic acumen to spearhead AI adoption at Novartis. In his current role, he orchestrates the rollout of key AI initiatives across vital U.S. functions—impacting finance, marketing, customer engagement and critical R&D areas like patient finding and insights generation. Collaborating closely with data science teams, he ensures these powerful tools are implemented strategically to maximize business impact, while also aiming to enhance AI literacy and accessibility throughout the organization. Rather than merely adapting to the future of pharma, Pasquali is actively shaping it.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/igniting-pharma-innovation-via-crosscultural-technology-nwid-2490.html